Jeevan Scientific Allocates Rs. 10 Crores for Naya Pharma Acquisition

Jeevan Scientific Technology Ltd has disclosed its plan to acquire a 60% stake in M/s. Naya Pharma Private Limited. The acquisition was approved at the Extraordinary General Meeting held on November 12, 2025. The company will utilize Rs. 10 Crores from the proceeds of a recent issue of convertible warrants and equity shares to fund this acquisition.

The financial structure for this acquisition involves the issuance and allotment of 35,00,000 convertible warrants to promoters and non-promoters, alongside 41,85,000 equity shares to non-promoters. The funds raised from this issuance will be directed towards the acquisition of M/s. Naya Pharma Private Limited. The total cost allocated for this acquisition is Rs. 10 Crores, which will be used to acquire a 60% stake in the company.

M/s. Naya Pharma Private Limited operates in the pharma sector, focusing on the manufacture and trade of Active Pharmaceutical Ingredients, drug intermediates, and various chemicals. The company was incorporated on August 19, 2020, and has a current paid-up capital of Rs. 3,66,70,330. The acquisition aligns with Jeevan Scientific’s strategy to diversify and expand its existing business operations, particularly in the clinical trials sector.

The acquisition process will be completed in phases, with no specific regulatory approvals required. The transaction is structured as a cash consideration, with the funds being sourced from the preferential issue of shares and warrants approved during the Extraordinary General Meeting.

Jeevan Scientific Technology Ltd is a company focused on providing diversified solutions in the scientific and technological sectors. The company’s strategic priorities include expanding its business operations and enhancing its service offerings in the clinical trials and pharmaceutical sectors.